Health insurance company Clover Health (NASDAQ:CLOV) in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was $0.03 above analysts’ consensus estimates.

Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over ...

Reports Q4 revenue $$336.96M , consensus $ ... achieves differentiated clinical and financial results,” said Clover Health (CLOV) CEO Andrew Toy. “As we move into a new phase of growth, we ...

CLOVER HEALTH ($CLOV) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of $0.02 per share, beating estimates of -$0.07 by ...

Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year at the midpoint Insurance revenue between $1.800 billion and $1.875 billion, representing 37% ...

Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share ...